|
Adrenoleukodystrophy Health Article
|
| Table of Contents |
Definition
X-linked adrenoleukodystrophy describes several closely related inherited disorders that disrupt the breakdown (metabolism) of certain fats (very-long-chain fatty acids).
Alternative Names
Adrenoleukodystrophy; Adrenomyeloneuropathy; Addison disease; Childhood cerebral adrenoleukodystrophy; ALD; Schilder-Addison Complex
Causes, incidence, and risk factors
Adrenoleukodystrophy is passed down from parents to their children as an X-linked genetic trait. It therefore affects mostly males, although some women who are carriers can have milder forms of the disease. It affects approximately 1 in 20,000 people from all races. The condition results in the buildup of very-long-chain fatty acids in the nervous system, adrenal gland, and testes, which disrupts normal activity. There are three major categories of disease:
Symptoms
Childhood cerebral type:
Adrenomyelopathy:
Adrenal gland failure (Addison type):
Signs and tests
Treatment
Adrenal dysfunction is treated with steroids (such as cortisol). A specific treatment for X-linked adrenoleukodystrophy is not available, but eating a diet low in very-long-chain fatty acids and taking special oils can lower the blood levels of very-long-chain fatty acids. These oils are called Lorenzo's oil, after the son of the family who discovered the treatment. This treatment is being tested for X-linked adrenoleukodystrophy, but it does not cure the disease and may not help all patients. Bone marrow transplant is also being tested as an experimental treatment. |
advertisement |
|
Use of this Web site constitutes acceptance of our Terms and Conditions of Use and Privacy Policy.